Management of Hyponatremia with Salt Tablets
Salt tablets can be effective for treating hyponatremia, with a recommended dose of 1-2 g (17-34 mEq) of sodium chloride 2-3 times daily, adjusted based on serum sodium monitoring and not exceeding correction rates of 4-6 mEq/L per day. 1
Diagnosis and Assessment of Hyponatremia
Before initiating salt tablet therapy, proper assessment is essential:
Categorize hyponatremia by severity:
- Mild: 130-135 mmol/L
- Moderate: 125-129 mmol/L
- Severe: <125 mmol/L 1
Determine volume status (critical for treatment selection):
Laboratory evaluation should include:
- Serum electrolytes
- Urinary sodium and potassium
- BUN/creatinine ratio 1
Salt Tablet Treatment Protocol
Indications for Salt Tablets
Salt tablets are most appropriate for:
- Mild to moderate hypovolemic hyponatremia
- Euvolemic hyponatremia when fluid restriction alone is insufficient
- Patients who can tolerate oral medications 1, 3
Dosing Guidelines
- Initial dose: 1-2 g (17-34 mEq) of sodium chloride 2-3 times daily
- Titrate based on serum sodium response
- Target correction rate: 4-6 mEq/L per day, not exceeding 8 mEq/L in 24 hours 1, 4
Monitoring Requirements
- Check serum sodium levels:
- Every 4-6 hours initially for symptomatic patients
- Daily for asymptomatic patients
- Monitor for signs of fluid overload in hypervolemic patients
- Assess for symptoms of osmotic demyelination syndrome (confusion, dysarthria, dysphagia, parkinsonism) 1, 5
Special Considerations by Volume Status
Hypovolemic Hyponatremia
- Salt tablets can be particularly effective
- May combine with normal saline infusion for more severe cases
- Monitor for resolution of hypovolemia 1, 3
Euvolemic Hyponatremia (e.g., SIADH)
- Combine salt tablets with fluid restriction (typically 500-1000 mL/day)
- Consider urea or vaptans if refractory to salt tablets and fluid restriction 1, 5
Hypervolemic Hyponatremia (e.g., Cirrhosis)
- Salt tablets are generally contraindicated due to fluid retention
- Focus on treating underlying condition and fluid restriction
- In cirrhosis, spironolactone (starting at 100 mg, up to 400 mg) is preferred 6, 1
Cautions and Contraindications
Avoid salt tablets in:
Risk of osmotic demyelination syndrome:
Practical Implementation
- Ensure adequate daily protein intake alongside salt supplementation
- For patients with cirrhosis and hyponatremia, temporarily discontinue diuretics if sodium <125 mmol/L 6
- In elderly patients, start with lower doses and monitor more frequently due to increased susceptibility to complications 1, 2
Salt tablets represent a practical approach for managing certain types of hyponatremia, but must be used with careful monitoring of serum sodium levels to prevent complications from both under-correction and over-correction.